« Previous
Next »
Advances in Chronic Kidney Disease
Volume 13, Issue 1
, Pages 62-69
, January 2006
Special Issues in Pediatric Kidney Transplantation
References
- 2004 SRTR Report on the state of transplantation (Pediatric transplantation 1994-2003) . Am J Transplant . 2005;5:887–903
-
North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). 2004 Annual Report
. Rockville, MD: EMMES Corporation; 2004;
- The 12th Annual Report of the North American Pediatric Renal Transplant Cooperative Study (Renal transplantation from 1987 through 1998) . Pediatr Transplant . 2001;5:215–231
- . Long-term survival of children with end-stage renal disease . N Engl J Med . 2004;350:2654–2662
-
.
USRDS 2004 annual data report. Pediatric ESRD
. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease; 2004;
- . Successful renal transplantation accelerates development in young uremic children . Pediatrics . 1990;86:594–600
- Growth and development in infants after renal transplantation . J Pediatr . 1987;110:343–350
- . Psychosocial adjustments to end-stage renal failure (comparing hemodialysis, continuous ambulatory peritoneal dialysis and transplantation) . Pediatr Nephrol . 1991;5:612–616
-
Differences in quality of life across renal replacement therapies
(A meta-analytic comparison)
.
Am J Kidney Dis
. 2000;35:
629–627
- . Psychosocial adaptation after solid organ transplantation in children . Pediatr Clin North Am . 2003;50:1505–1519
-
Changing trends in pediatric transplantation
(2001 annual report of the North American Pediatric Renal Transplant Cooperative Study)
.
Pediatr Transplant
. 2003;7:
321–235
-
2004 OPTN/SRTR Annual Report 1994-2003. HHS/HRSA/HSB/DOT;UNOS; URREA. Available at: www.ustransplant.org.
- Renal replacement therapy in children (Data from 12 registries in Europe) . Pediatr Nephrol . 2004;19:213–221
-
.
Post-transplant infections now exceed acute rejection as cause for hospitalization
(A report of the NAPRTCS)
.
Am J Transplant
. 2004;3:384–389
- . Neurologic-developmental sequelae of chronic renal failure in infancy . J Pediatr . 1985;106:579–583
- Progressive encephalopathy in children with chronic renal insufficiency in infancy . Kidney Int . 1982;21:486–491
-
.
Neurodevelopmental outcome of children initiating peritoneal dialysis in early infancy
.
Pediatr Nephrol
. 1999;13:
759–665
- Beneficial effect of renal transplantation on cognitive brain function . Kidney Int . 1996;49:833–838
- . Improvement in specific aspects of neurocognitive performance in children after renal transplantation . Kidney Int . 1999;56:318–323
- Differences in quality of life across renal replacement therapies (A meta-analytic comparison) . Am J Kidney Dis . 2000;35:629–637
- Cognitive functioning in children on dialysis and post-transplantation . Pediatr Transplant . 2000;4:261–267
- Pediatric transplantation of the kidney, liver and heart (Summary report) . Pediatr Transplant . 2004;8:75–86
- . Skeletal growth in experimental uremia . Kidney Int . 1983;24:53–62
- Effect of growth hormone treatment on the adult height of children with chronic renal failure. German Study Group for Growth Hormone Treatment in Chronic Renal Failure . N Engl J Med . 2000;343:923–930
- Outcome and growth of infants with severe chronic renal failure . Kidney Int . 2000;57:1681–1687
-
.
A longitudinal study of the natural history of growth post-transplantation
.
Kidney Int
. 1996;53(suppl):103–108
- . The contribution of renal transplantation to final adult height (A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)) . Pediatr Nephrol . 2001;16:951–956
- Growth after renal transplantation in infancy or early childhood . Pediatr Nephrol . 2002;17:438–443
- Growth impairment at renal transplantation (A determinant of growth and final height) . Pediatr Transplant . 2003;7:192–199
- Factors predictive of sustained growth in children after renal transplantation. The North American Pediatric Renal Transplant Cooperative Study . J Pediatr . 1993;122:397–402
- Alternate-day steroid dosing improves growth without adversely affecting graft survival or long-term graft function. A report of the North American Pediatric Renal Transplant Cooperative Study . Transplantation . 1996;61:31–36
-
Steroid withdrawal, rejection and the mixed lymphocyte reaction in children after renal transplantation
.
Kidney Int
. 1993;43(suppl):S36–S39
- Follow-up of cyclosporine-treated pediatric renal allograft recipients after cessation of prednisone . Transplantation . 1990;49:76–80
- Successful withdrawal of steroids in pediatric renal transplant recipients receiving cyclosporine A and mycophenolate mofetil treatment (Results after four years) . Transplantation . 2004;78:228–234
- Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation . Transplantation . 2003;76:1331–1339
- Growth in children after kidney transplantation with living related donor graft or cadaveric graft . Lancet . 2005;366:151–153
- . Randomized controlled trial of recombinant human growth hormone in prepubertal and pubertal renal transplant recipients . Arch Dis Child . 1998;79:481–487
- Effects of growth hormone in short children after renal transplantation . Pediatr Nephrol . 1998;12:437–446
- . Long-term use of recombinant human growth hormone in pediatric allograft recipients (A report of the NAPRTCS Transplant Registry) . Pediatr Nephrol . 2005;20:404–408
-
.
Infections in solid organ transplantation
.
In:
Long S
, Pickering L
, Prober C
editor.
Principles and Practice of Pediatric Infectious Diseases
. Philadelphia, PA: Elsevier Health Sciences; 2002;p. 554–561
- . Infectious complications in pediatric solid organ transplantation . Pediatr Clin North Am . 2003;50:1451–1469
-
.
Immunization of children with renal disease
.
In:
Kaplan BS
, Meyers KEC
editor.
Pediatric Nephrology and Urology. The Requisites in Pediatrics
. Philadelphia, PA: Elsevier Mosby; 2004;p. 33–40
- Post-transplant lymphoproliferative disease in children . Pediatr Transplant . 2001;5:250–257
- Epstein-Barr virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression . Transplantation . 1999;68:997–1003
- Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation (A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)) . Transplantation . 2001;71:1065–1068
-
Mycophenolate, tacrolimus and post-transplant lymphoproliferative disorder
(A report of the North American Pediatric Renal Transplant Cooperative Study)
.
Pediatr Transplantation
. 2002;6:396–399
- Improved cadaveric renal transplant outcomes in children . Pediatr Nephrol . 1991;5:137–142
- Noncompliance in a pediatric renal transplant population . Transplant Proc . 1994;26:129
- Transplant allograft loss in the adolescent patient . Adv Ren Replace Ther . 1996;3:154–165
-
Is noncompliance among adolescent renal transplant recipients inevitable?
.
Pediatr
. 2005;115:969–973
- Late renal allograft loss (Noncompliance masquerading as chronic rejection) . Transplant Proc . 1999;31(suppl A):21S–23S
- . Demographic and medical predictors of medication compliance among ethnically different pediatric renal transplant patients . Pediatr Transplant . 2001;5:343–348
- Assessing associations between medication adherence and potentially modifiable psychosocial variables in pediatric kidney transplant recipients and their families . Pediatr Transplant . 2004;8:543–550
- . Non-adherence in pediatric transplantation (A review of the existing literature) . Pediatr Transplant . 2001;5:246–249
- Comparison of FK-506 and cyclosporine regimens in pediatric renal transplantation . Pediatr Nephrol . 1994;8:193–200
- Conversion from cyclosporine to tacrolimus is preferred by pediatric renal transplant cooperative recipients (A focus on opinions and outcomes) . Transplant Proc . 2002;34:1951–1952
Dr. Neu has received unrestricted educational grants from and had a speaker’s agreement with Fujisawa Pharmaceutical Company, Ltd, now Astellas Pharma US, Inc.
PII: S1548-5595(05)00193-X
doi: 10.1053/j.ackd.2005.10.001
© 2006 National Kidney Foundation, Inc. Published by Elsevier Inc All rights reserved.
« Previous
Next »
Advances in Chronic Kidney Disease
Volume 13, Issue 1
, Pages 62-69
, January 2006
